166 related articles for article (PubMed ID: 9137104)
61. Medullary carcinoma of the colon: A comprehensive analysis of the National Cancer Database.
Jabbal IS; Nagarajan A; Rivera C; Yaghi M; Liang H; Nahleh Z; Bejarano P; Berho M; Wexner S
Surg Oncol; 2022 Dec; 45():101856. PubMed ID: 36446307
[TBL] [Abstract][Full Text] [Related]
62. Colorectal medullary carcinoma: heterogeneous presentations of a rare clinico-pathological entity. Report of two cases.
Romanzi A; Centonze G; Sabella G; Cattaneo L; Battiston C; Lorenzo ND; Milanesi M; Putortì A; Rossi F; Scolaro R; Zanardo M; Vignati B; Vannelli A
Tumori; 2022 Dec; 108(6):NP20-NP25. PubMed ID: 35311395
[TBL] [Abstract][Full Text] [Related]
63. Medullary colonic carcinoma with microsatellite instability has lower survival compared with conventional colonic adenocarcinoma with microsatellite instability.
Gómez-Álvarez MA; Lino-Silva LS; Salcedo-Hernández RA; Padilla-Rosciano A; Ruiz-García EB; López-Basave HN; Calderillo-Ruiz G; Aguilar-Romero JM; Domínguez-Rodríguez JA; Herrera-Gómez Á; Meneses-García A
Prz Gastroenterol; 2017; 12(3):208-214. PubMed ID: 29123583
[TBL] [Abstract][Full Text] [Related]
64. Medullary carcinoma of the small bowel.
Brcic I; Cathomas G; Vanoli A; Jilek K; Giuffrida P; Langner C
Histopathology; 2016 Jul; 69(1):136-40. PubMed ID: 26599717
[TBL] [Abstract][Full Text] [Related]
65. Primary Colonic Medullary Carcinoma With Exclusive Squamous Differentiation.
Chen IY; Findeis-Hosey JJ; Cannon L; Liao X
Anticancer Res; 2021 Jul; 41(7):3567-3572. PubMed ID: 34230152
[TBL] [Abstract][Full Text] [Related]
66. Microsatellite Instability in Medullary Carcinoma of the Colon.
Martinotti M; Cirillo F; Ungari M; Tanzi G; Rolando G; Tarasconi A; Ranieri V; Aulisa P; Vismarra M; Rovatti M; Trombatore M
Rare Tumors; 2017 Mar; 9(1):6541. PubMed ID: 28458789
[TBL] [Abstract][Full Text] [Related]
67. p53 mutation as a genetic trait of typical medullary breast carcinoma.
de Cremoux P; Salomon AV; Liva S; Dendale R; Bouchind'homme B; Martin E; Sastre-Garau X; Magdelenat H; Fourquet A; Soussi T
J Natl Cancer Inst; 1999 Apr; 91(7):641-3. PubMed ID: 10203285
[No Abstract] [Full Text] [Related]
68. Medullary colorectal carcinoma. Do we really know it?
Puerta Vicente A; Vilar Tabanera A; García Pérez JC
Rev Esp Enferm Dig; 2020 Jul; 112(7):579-580. PubMed ID: 32579007
[TBL] [Abstract][Full Text] [Related]
69. Pleomorphic Carcinoma of the Colon: Morphological and Immunohistochemical Findings.
Branca G; Barresi V; Ieni A; Irato E; Caruso RA
Case Rep Gastroenterol; 2016; 10(2):233-40. PubMed ID: 27462191
[TBL] [Abstract][Full Text] [Related]
70. Correction: Colonic medullary carcinoma: an exceedingly rare type of colorectal malignancy: a case report and review of the literature.
Al-Ishaq F; Al-Dhaheri M; Toffaha A; Awad S; Rizvi S; AbuNada M; Kurer M
J Med Case Rep; 2023 Nov; 17(1):483. PubMed ID: 37915095
[No Abstract] [Full Text] [Related]
71. [Medullary plasma and pseudo-plasma cells in neoplasms].
MOREL P
Sang; 1949; 20(9):602-8. PubMed ID: 15404935
[No Abstract] [Full Text] [Related]
72. Medullary colonic carcinomas present with early-stage disease and do not express neuroendocrine markers by immunohistochemistry.
Abada E; Jang H; Kim S; Abada O; Beydoun R
Ann Gastroenterol; 2023; 36(3):321-326. PubMed ID: 37144022
[TBL] [Abstract][Full Text] [Related]
73. Medullary Carcinoma of the Gastrointestinal Tract: Report on Two Cases with Immunohistochemical and Molecular Features.
Colarossi C; Mare M; La Greca G; De Zuanni M; Colarossi L; Aiello E; Piombino E; Memeo L
Diagnostics (Basel); 2021 Sep; 11(10):. PubMed ID: 34679473
[TBL] [Abstract][Full Text] [Related]
74. Sidedness determines clinical characteristics and survival outcomes in medullary adenocarcinoma of the colon.
Blakely AM; Nelson RA; Hamilton SA; Lai LL
Sci Rep; 2021 Oct; 11(1):20481. PubMed ID: 34650170
[TBL] [Abstract][Full Text] [Related]
75. Tumor-Infiltrating Lymphocytes, Tumor Mutational Burden, and Genetic Alterations in Microsatellite Unstable, Microsatellite Stable, or Mutant
Keshinro A; Vanderbilt C; Kim JK; Firat C; Chen CT; Yaeger R; Ganesh K; Segal NH; Gonen M; Shia J; Stadler Z; Weiser MR
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250404
[TBL] [Abstract][Full Text] [Related]
76. Optimal Criteria for G3 (Poorly Differentiated) Stage II Colon Cancer: Prospective Validation in a Randomized Controlled Study (SACURA Trial).
Ueno H; Ishiguro M; Nakatani E; Ishikawa T; Uetake H; Matsui S; Teramukai S; Murotani K; Ajioka Y; Shimazaki H; Maeda A; Takuma K; Yoshida T; Kambara T; Matsuda K; Takagane A; Tomita N; Sugihara K;
Am J Surg Pathol; 2020 Dec; 44(12):1685-1698. PubMed ID: 32868525
[TBL] [Abstract][Full Text] [Related]
77. Patient-individual cancer cell lines and tissue analysis delivers no evidence of sequences from DNA viruses in colorectal cancer cells.
Gock M; Kordt M; Matschos S; Mullins CS; Linnebacher M
BMC Gastroenterol; 2020 Aug; 20(1):260. PubMed ID: 32762707
[TBL] [Abstract][Full Text] [Related]
78. Solid-type poorly differentiated adenocarcinoma of the stomach: Deficiency of mismatch repair and SWI/SNF complex.
Tsuruta S; Kohashi K; Yamada Y; Fujiwara M; Koga Y; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
Cancer Sci; 2020 Mar; 111(3):1008-1019. PubMed ID: 31922331
[TBL] [Abstract][Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
